BioNTech SE 20-F for FY2024
BioNTech SE (BNTX)
20-F
2025-03-10
For: 2024-12-31
View Original
Added on
April 07, 2026
About this 20-F
BioNTech SE filed this 20-F on March 10, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 2.75B EUR
- down 28.0% from 3.82B EUR a year earlier
- Net loss
- 665.3M EUR
- compared with net income of 930.3M EUR a year earlier
- Diluted EPS
- -2.77 EUR
- compared with 3.83 EUR a year earlier